LCTX
AMEX
$1.11
Lineage Cell Therapeutics Inc (LCTX)
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing therapeutics for the treatment of degenerative diseases in the United States and internationally. The company is headquartered in Carlsbad, California.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $5.50 (+395.50%)
Market Cap
$305M
EPS 5Y CAGR
+28.54%
Revenue 5Y CAGR
+54.06%
Free Cash Flow Yield
-7.40%
Price Chart
Valuation
Market Cap$305M
Forward P/E30.67
P/S20.58
P/B5.65
Profitability
Total Revenue (TTM)$15M
Gross Profit (TTM)-$4.18M
EBITDA-$37M
Operating Margin-440.2%
EPS-$0.28
Financial Health
Free Cash Flow Yield-7.40%
Growth & Risk
EPS 5Y CAGR+28.54%
Revenue 5Y CAGR+54.06%
FCF 5Y CAGR+0.34%
Beta (5Y)1.15
Sharpe Ratio0.43